Purpose: The study was performed to assess the maximum flow rate(Qmax) through the uroflowmetry and
to examine the relation between Maximum Flow Rate(Qmax) and Hoehn & Yahr stage.
Methods: The subjects were 53 patients(14 men, 39 women) with Parkinson's disease
who had been visiting the Neurology clinic at a university hospital from September to November 2005.
We assessed Qmax score by uroflowmetry in neurology clinic.
Results: Mean score of Qmax was 14.13 ml/sec for men and 16.64 ml/sec for women.
Qmax by Hoehn & Yahr stage was 22,12 ml/sec at stage one(N=10), 15.29 ml/sec ay stage two(N=24),
and 13.61 ml/sec at stage three(N=19) and they were significantly different(F=4.9, p=0.011).
In Qmax score , Subjects with >15 ml/sec were 25, and £15 ml/sec were 28. Negative correlation was observed
between Hoehn & Yahr stage and Qmax(r=-369, p=0.006).
to examine the relation between Maximum Flow Rate(Qmax) and Hoehn & Yahr stage.
Methods: The subjects were 53 patients(14 men, 39 women) with Parkinson's disease
who had been visiting the Neurology clinic at a university hospital from September to November 2005.
We assessed Qmax score by uroflowmetry in neurology clinic.
Results: Mean score of Qmax was 14.13 ml/sec for men and 16.64 ml/sec for women.
Qmax by Hoehn & Yahr stage was 22,12 ml/sec at stage one(N=10), 15.29 ml/sec ay stage two(N=24),
and 13.61 ml/sec at stage three(N=19) and they were significantly different(F=4.9, p=0.011).
In Qmax score , Subjects with >15 ml/sec were 25, and £15 ml/sec were 28. Negative correlation was observed
between Hoehn & Yahr stage and Qmax(r=-369, p=0.006).
Conclusions: The above findings suggested that the severer Parkinson’ disease was, the lower Qmax was.